10-K - Vycor Medical, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Vycor Medical navigated a challenging fiscal year 2025, achieving revenue growth and a return to positive operating income, yet persistent net losses and negative free cash flow underscore significant ongoing financial pressures.

Key Takeaways

1Revenue grew 17.2% year-over-year to $1.9 million, reflecting the company's continued commercial execution.

2Gross profit increased 9.7% to $1.6 million, though the gross margin of 83.8% reflects pressure from validation, shipping, higher manufacturing costs, and a higher international sales mix.

3Operating income turned positive at $33.9 thousand, a 470.7% improvement, as the company managed its cost structure effectively.

4The net loss narrowed by 32.4% to -$72.4 thousand, yet free cash flow was -$18.7 thousand as operating cash flow turned negative.

5The company's strategy includes engaging Maxim Group LLC for strategic advisory services, with related amortization charges impacting expenses.

6Management notes that while inflation may increase costs of sales, it is not expected to have a material effect on business results.

Key Financial Metrics

EPS

$-0.01

0.0%

Revenue

$1.9M

17.2%

Net Income

-$72.4K

32.4%

Gross Margin

83.8%

Gross Profit

$1.6M

9.7%

free cash flow

-$18.7K

Operating Income

$33.9K

470.7%

operating margin

1.8%